CAMBRIDGE, UK & BILLERICA, Mass.--(BUSINESS WIRE)--Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ...

Digital microfluidics and biochip technologies represent a rapidly evolving interdisciplinary field that integrates principles of physics, chemistry and engineering to manipulate discrete droplets ...

Drug developers are consistently aiming to enhance clinical relevance in drug discovery. CRISPR has emerged as a versatile tool to accelerate the entire drug discovery process, with arrayed CRISPR ...

Most cells in the human body exist in complex three-dimensional environments, yet they are still commonly studied on flat plastic dishes. These two-dimensional cultures distort cell behavior, limiting ...

(Nanowerk Spotlight) For decades, microfluidics has held promise as a revolutionary technology, yet widespread adoption outside research labs has remained elusive. Microfluidic devices enable precise ...

(Nanowerk Spotlight) Microfluidics, the science of manipulating tiny amounts of fluid in micro-scale devices, has long held promise for revolutionizing fields like medical diagnostics, chemistry, and ...

This review provides a comprehensive overview of the latest advances in droplet microfluidics, with a particular focus on its ...

CAMBRIDGE, UK & BILLERICA, Mass.--(BUSINESS WIRE)--Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ...

UK-based biotech firm Nuclera has announced it has acquired Taiwan-based E Ink Holdings (EIH)'s digital microfluidics unit to form its US subsidiary. Combining the technologies of the two companies ...

This morning, E Ink announced that their digital microfluidics unit has been acquired by Nuclera, a UK-based biotech company. The acquisition combines the tech of the two companies to create a desktop ...